Nós utilizamos cookies para otimizar o website. Se você continuar navegando no site ou se fechar esta janela, você aceita nossa política de cookies

Esse conteúdo do nosso site está disponível apenas em inglês
Imprimir Compartilhe

Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S

Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S
Press ReleaseJan 29. 2018 09:07 GMT

Christoffer Lorenzen (42) is Executive Vice President (EVP) of Chr. Hansen’s largest business unit, Food Cultures & Enzymes. He joined Chr. Hansen in March 2008 and has held various positions in Sales and Marketing, including Director of Marketing in our Animal Health & Nutrition Business, and Vice President of Central & Eastern Europe. In 2013 he was appointed Senior Vice President of Commercial Development in the Cultures & Enzymes Division and in 2016 he was appointed EVP of the Food Cultures and Enzymes Business Unit.

Prior to joining Chr. Hansen, Mr Lorenzen was employed at H. Lundbeck A/S, a global specialty pharmaceutical company, where he served as Head of Corporate Strategy and M&A as well as Corporate Secretary.

Christoffer Lorenzen holds a Master in Business (Marketing) 2002 from the Copenhagen Business School.

“The appointment of Christoffer Lorenzen to the Executive Board of Chr. Hansen had been planned already before the announcement of Cees de Jong stepping back, as FC&E has normally always been represented at the Executive Board.” says Ole Andersen Chairman of Chr. Hansen.

CEO Cees de Jong adds: “Christoffer has been with Chr. Hansen for the past 10 years and has a deep knowledge and understanding of the company, its history and its potential. By joining, Christoffer adds core knowledge and expertise to the Executive Board.”

The company strategy, priorities and financial guidance remain the same.

As of 1 February, 2018, the Executive Board consists of: CEO Cees de Jong, CFO Søren Westh Lonning, CSO Thomas Schäfer, and EVP Christoffer Lorenzen. The Executive Board is appointed by the Board of Directors and is, together with their colleagues in the Corporate Leadership Team, responsible for day-to-day management and compliance with the guidelines and directions given by the Board of Directors.

For further information, please contact:
Martin Riise, Head of Investor Relations, Tel: +45 53 39 22 50
Helle Rexen, Interim Head of Media Relations, Tel: +45 20 74 28 40


A Chr. Hansen é uma empresa global de biociência, que desenvolve soluções com ingredientes naturais para as indústrias alimentícia, nutricional, farmacêutica e agrícola. Os produtos incluem culturas, enzimas, probióticos e corantes naturais, e todas as soluções baseiam-se em sólidas competências em pesquisa e desenvolvimento, além de significativos investimentos em tecnologia. A receita para o ano fiscal 2015/16 foi de 949 milhões de euros. A empresa tem mais de 2.800 funcionários em 30 países, e centros principais de produção na Dinamarca, França, EUA e Alemanha. A Chr. Hansen foi fundada em 1874 e está listada na Nasdaq Copenhague.

O que você procura?

Compartilhe esta página

Selecione o seu idioma de preferência